Viridian Therapeutics Ors Inc (VRDN)

CapEx to Revenue

2.38%

TTM · Retrieved:

VRDN logo

VRDN CapEx to Revenue

Current (TTM)2.38%
VRDN CapEx/Revenue (2.43% → 2.38%)
High-resolution chart · PNG

VRDN capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Viridian Therapeutics Ors Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.6987%
169.2053%
285.9873%
44.9774%
11.4074%
4%
1.883%
5.3065%
6.1454%
0.0899%
4.8463%
6.1574%
0.1105%
2.4265%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.